Technology Access
Technology Access - Related Videos
09:45
Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology
0 Views •
Cited by 71 •
2019
This protocol details the steps, costs, and equipment necessary to generate E. coli-based cell extracts and implement in vitro protein synthesis reactions within 4 days or less. To leverage the flexible nature of this platform for broad applications, we discuss reaction conditions that can be adapted and optimized.
14:37
Accessibility to Clinical Care for People who use Wheelchairs
0 Views •
2023
Source: Yetsa Tuakli-Wosornu1,2, Jaideep Talwalkar1; 1Yale School of Medicine, 2University of Pittsburgh In the United States, 25% of the general population suffers from one or another type of disability. Ambulatory disabilities, or mobility impairments, represent the most common subcategory, comprising 14% of the country's populace. Different mobility-assistive devices, ranging from canes to scooters, enable increased independence and improved quality of life for those suffering from mobility...
01:26
Technological Change
0 Views •
2024
Total Factor Productivity (TFP) measures the efficiency with which inputs are transformed into outputs in production. It is the essence of economic growth, driven by technological advancement. Consider the agricultural sector, where production requires vast amounts of human labor and work animals. Today, modern farm machinery and agriculture technologies have revolutionized how we cultivate crops and produce food much more efficiently. TP = A*f(K, L) TFP is represented as a multiplier 'A' in...
01:31
Hybridoma Technology
0 Views •
2023
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy. Hybridoma Selection Commonly used fusion techniques — electroporation, polyethylene glycol...
11:56
Central Venous Access Device Dressing Change
0 Views •
2023
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT Central venous access devices (CVAD), commonly known as central lines or central catheters, are large-bore intravenous (IV) catheters that are introduced into the central circulation. Typically, CVADs terminate in the superior vena cava, just outside of the right atrium of the heart, but they may also terminate in any one of the great veins (i.e., aorta, inferior vena cava, brachiocephalic...
FAQs
Affordability influences technology access by determining whether patients and healthcare systems can obtain and sustain tools needed for care. Physical infrastructure and internet connectivity add further conditions: even an affordable technology may provide little benefit where facilities, networks, or reliable connections are inadequate. Considering these factors together helps explain unequal implementation.
Technology access depends on more than acquisition because users must be able to operate tools and benefit from them. Digital literacy supports effective use of information and services, while training helps healthcare personnel integrate technologies into care. If either is insufficient, a device or platform may exist without functioning reliably in routine medical workflows.
Procurement shapes access by influencing whether a healthcare system can obtain suitable technologies and maintain their use in practice. It should be considered alongside affordability, infrastructure, connectivity, and training rather than treated as an isolated purchasing step. This broader view helps identify why an innovation may not translate into dependable care for intended users.
Availability alone is insufficient because technologies must also be usable and beneficial in the setting where care occurs. A service may be present, yet limited connectivity, unaffordable costs, inadequate skills, or missing training can prevent patients and clinicians from using it effectively. Evaluating these barriers reveals whether access produces practical improvements rather than nominal availability.
Before implementing a medical technology, a team should examine affordability, physical infrastructure, internet connectivity, digital literacy, procurement, and training. These factors indicate whether the proposed tool can operate reliably and be used by its intended population. Reviewing them early supports practical design and helps teams anticipate barriers before evaluating effects on care.
Telemedicine and remote monitoring are important applications because they can connect underserved communities with clinicians and support ongoing care outside conventional settings. Their value depends on surrounding access conditions, especially connectivity, affordability, user skills, and training. Assessing those conditions helps determine whether the technology expands meaningful care or remains difficult to use.
Studying Technology Access helps researchers and health systems identify barriers associated with unequal care and evaluate whether an innovation works in real-world settings. Findings can guide the design, implementation, and evaluation of medical tools, information, and services. This context shifts attention from the technology alone toward conditions required for reliable benefit across communities.